Cutaneous Manifestations Associated With COVID-19 Infection at a University Hospital in Eastern China

This study found that hospitalized pediatric COVID-19 patients frequently display skin, mucosal, and nail manifestations, particularly periorbital erythema and edema, and the authors suggest COVID-19 be considered among childhood viral exanthem rashes.

In this study, among patients with COVID-19 and skin lesions, male sex, ICU admission, and the use of three or more antibiotics were associated with higher mortality, while patterns of cutaneous manifestations were not linked to mortality.

This review discusses various skin manifestations associated with COVID-19, emphasizing their potential role in early diagnosis and management of the infection, but reports no new clinical findings.

This review summarizes existing and new cases of generalized pustular psoriasis and acute generalized exanthematous pustulosis associated with COVID-19, noting that over half lacked a known drug trigger.

This review suggests that alopecia areata may occur as a dermatologic manifestation of COVID-19, often appearing 1 to 2 months after infection; further research is needed to clarify this association.

This study found that patients who recovered from COVID-19 experienced various skin, hair, and nail issues, with hair shedding being more common in those with moderate to severe cases.

This study discusses hair loss as a potential late-onset symptom of COVID-19 recovery, with androgenic alopecia and telogen effluvium suggested as possible causes, but provides no new clinical results.

This review discusses the complex pathophysiological and clinical aspects of COVID-19, including dermatological findings and their association with SARS-CoV-2 infection but reports no new clinical results.